Update in transplantation 2007

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 10, 2008, Pages 1062-1067

  Corris, Paul A ^a   Christie, Jason D ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; METHYLPREDNISOLONE; PROTON PUMP INHIBITOR; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; LUNG FIBROSIS; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TREATMENT INDICATION; ADULT; ANIMAL; CHILD; DISEASE MODEL; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; HETEROZYGOTE; METHODOLOGY; MICROBIOLOGY; PATIENT SELECTION; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

ADULT; ANIMALS; BRONCHIOLITIS OBLITERANS; CARRIER STATE; CHILD; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; PATIENT SELECTION; RESPIRATORY TRACT INFECTIONS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 43849100761     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200802-247UP     Document Type: Review

References (65)

1. Corris PA, Christie JD. Update in transplantation 2006. Am J Respir Crit Care Med 2007;175:432-435.
2. Garrity ER, Moore J, Mulligan MS, Shearon TH, Zucker MJ, Murray S. Heart and lung transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1390-1403.
3. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007;26:782-795.
4. Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357:2143-2152.
5. Aurora P, Whitehead B, Wade A, Bowyer J, Whitmore P, Rees PG, Tsan VT, Elliott MJ, de Leval M. Lung transplantation and life extension in children with cystic fibrosis. Lancet 1999;354:1591-1593.
6. Belkin RA, Henig NR, Singer LG, Chaparro C, Rubenstein RC, Xie SX, Yee JY, Kotloff RM, Lipson DA, Bunin GR. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006;173:659-666.
7. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-27.
8. Hadjiliadis D, Steele MP, Chaparro C, Singer LG, Waddell TK, Hutcheon MA, Davis RD, Tullis DE, Palmer SM, Keshavjee S. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007;26:834-838.
9. Goerler H, Simon A, Gohrbandt B, Hagl C, Oppelt P, Weidemann J, Haverich A, Strueber M. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardiothorac Surg 2007;32:926-931.
10. Ferrer J, Rodriguez AR. Factors related to postoperative mortality in lung transplantation for emphysema. Transplant Proc 2007;39:3317-3322.
11. Gries CJ, Mulligan MS, Edelman JD, Raghu G, Curtis JR, Goss CH. Lung allocation score for lung transplantation: impact on disease severity and survival. Chest 2007;132:1954-1961.
12. Mason DP, Brizzio ME, Alster JM, McNeill AM, Murthy SC, Budev MM, Mehta AC, Minai OA, Pettersson GB, Blackstone EH. Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg 2007;84:1121-1128.
13. Russo MJ, Sternberg DI, Hong KN, Sorabella RA, Moskowitz AJ, Gelijns AC, Wilt JR, D'Ovidio F, Kawut SM, Arcasoy SM, et al. Postlung transplant survival is equivalent regardless of cytomegalovirus match status. Ann Thorac Surg 2007;84:1129-1134. [Discussion, pp. 1134-1125.]
14. Gutierrez C, Al-Faifi S, Chaparro C, Waddell T, Hadjiliadis D, Singer L, Keshavjee S, Hutcheon M. The effect of recipient's age on lung transplant outcome. Am J Transplant 2007;7:1271-1277.
15. Nwakanma LU, Simpkins CE, Williams JA, Chang DC, Borja MC, Conte JV, Shah AS. Impact of bilateral versus single lung transplantation on survival in recipients 60 years of age and older: analysis of United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2007;133:541-547.
16. Mitchell PO, Guidot DM. Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation. Am J Respir Crit Care Med 2007;176:1161-1168.
17. Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007;7:2396-2405.
18. Steen S, Ingemansson R, Eriksson L, Pierre L, Algotsson L, Wierup P, Liao Q, Eyjolfsson A, Gustafsson R, Sjoberg T. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007;83:2191-2194.
19. De Perrot M, Waddell TK, Shargall Y, Pierre AF, Fadel E, Uy K, Chaparro C, Hutcheon M, Singer LG, Keshavjee S. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007;133:525-531.
20. Venkateswaran RV, Patchell VB, Wilson IC, Mascaro JG, Thompson RD, Quinn DW, Stockley RA, Coote JH, Bonser RS. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008;85:278-286. [Discussion, p. 286.]
21. de Antonio DG, Marcos R, Laporta R, Mora G, Garcia-Gallo C, Gamez P, Cordoba M, Moradiellos J, Ussetti P, Carreno MC, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 2007;26:529-534.
22. Nishi H, Date H, Aoe M, Shimuzu N. Canine bilateral lung transplantation after 18-hour preservation using non-heart-beating donors. J Heart Lung Transplant 2007;26:610-616.
23. Van De Wauwer C, Neyrinck AP, Geudens N, Rega FR, Verleden GM, Verbeken E, Lerut TE, Van Raemdonck DE. Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung. Eur J Cardiothorac Surg 2007;31:1125-1132. [Discussion, pp. 1132-1123.]
24. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007;175:507-513.
25. Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, Dahlberg PS. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007;26:1004-1011.
26. Burton CM, Iversen M, Milman N, Zemtsovski M, Carlsen J, Steinbruchel D, Mortensen J, Bersen C. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 2007;31:75-82.
27. Bharat A, Narayanan K, Street T, Fields RC, Steward N, Aloush A, Meyers B, Schuessler R, Trulock EP, Patterson GA, Mohanakumar T. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007;83:150-158.
28. Calfee CS, Budev MM, Matthay MA, Church G, Brady S, Uchida T, Ishizaka A, Lara A, Ranes JL, deCamp MM, et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant 2007;26:675-680.
29. Frank JA, Briot R, Lee JW, Ishizaka A, Uchida T, Matthay MA. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007;293:L52-L59.
30. Christie JD, Robinson N, Ware LB, Plotnick M, Derade J, Lama V, Milstone A, Orens J, Weinacker A, Demissie E, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007;175:69-74.
31. Covarrubias M, Ware LB, Kawut SM, J De Andrade, Milstone A, Weinacker A, Orens J, Lama V, Wille K, Bellamy S, et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007;7:2573-2578.
32. Hanusch C, Nowak K, Gill IS, Torlitz P, Rafat N, Mueller AM, Van Ackern KC, Yard B, Beck GC. Hypothermic preservation of lung allograft inhibits cytokine-induced chemoattractant-1, endothelial leucocyte adhesion molecule, vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression. Clin Exp Immunol 2007;149:364-371.
33. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S. Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 2007;7:700-706.
34. Prekker ME, Herrington CS, Hertz MI, Radosevich DM, Dahlberg PS. Early trends in PaO(2)/fraction of inspired oxygen ratio predict outcome in lung transplant recipients with severe primary graft dysfunction. Chest 2007;132:991-997.
35. Gonzalez-Castro A, Llorca J, Buron J, C Gonzalez-Mansilla, F Ortiz-Melon, E Minambres. Evaluation of the oxygenation ratio as long-term prognostic marker after lung transplantation. Transplant Proc 2007;39:2422-2424.
36. Oto T, Levvey BJ, Snell GI. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system. J Heart Lung Transplant 2007;26:431-436.
37. Fischer S, Bohn D, Rycus P, Pierre AF, de Perrot M, Waddell TK, Keshavjee S. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant 2007;26:472-477.
38. Wigfield CH, Lindsey JD, Steffens TG, Edwards NM, Love RB. Early institution of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation improves outcome. J Heart Lung Transplant 2007;26:331-338.
39. Kermeen FD, McNeil KD, Fraser JF, McCarthy J, Ziegenfuss MD, Mullany D, Dunning J, Hopkins PM. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant 2007;26:850-856.
40. Struber M, Fischer S, Niedermeyer J, Warnecke G, Gohrbandt B, Gorler A, Simon AR, Haverich A, Hohlfeld JM. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 2007;133:1620-1625.
41. Avlonitis VS, Wigfield CH, Golledge HD, Kirby JA, Dark JH. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant 2007;7:83-90.
42. Geudens N, Van De Wauwer C, Neyrinck AP, Timmermans L, Vanhooren HM, Vanaudenaerde BM, Verleden GM, Verbeken E, Lerut T, Van Raemdonck DE. N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant 2007;26:1326-1332.
43. Inci I, Zhai W, Arni S, Inci D, Hillinger S, Lardinois D, Vogt P, Weder W. N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg 2007;84:240-246. [Discussion, p. 246.]
44. Kohmoto J, Nakao A, Stolz DB, Kaizu T, Tsung A, Ikeda A, Shimizu H, Takahashi T, Tomiyama K, Sugimoto R, et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 2007;7:2279-2290.
45. Liu H, Liu L, Fletcher BS, Visner GA. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury. Am J Respir Crit Care Med 2006;173:566-572.
46. Liu H, Liu L, Visner GA. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am J Transplant 2007;7:2291-2300.
47. Mori H, Nagahiro I, Osaragi T, Kotani K, Nakanishi H, Sano Y, Date H, Shimizu N. Addition of a neutrophil elastase inhibitor to the organ flushing solution decreases lung reperfusion injury in rat lung transplantation. Eur J Cardiothorac Surg 2007;32:791-795.
48. Suzuki S, Sugawara T, Tabata T, Oishi H, Niikawa H, Kondo T. Sivelestat reduces reperfusion injury of lungs harvested from endotoxin-primed rats by inhibition of neutrophil-mediated inflammation. J Heart Lung Transplant 2007;26:370-375.
49. Okazaki M, Kreisel F, Richardson SB, Krupnick AS, patterson GA, Gelman AE. Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. Am J Transplant 2007;7:751-758.
50. Makiuchi A, Yamaura K, Mizuno S, Matsumoto K, Nakamura T, Amano J, Ito K. Hepatocyte growth factor prevents pulmonary ischemia-reperfusion injury in mice. J Heart Lung Transplant 2007;26:935-943.
51. Zhai W, Cardell M, De Meester I, Augustyns K, Hillinger S, Inci I, Arni S, Jungraithmayr W, Scharpe S, Weder W, Korom S. Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. J Heart Lung Transplant 2007;26:174-180.
52. Hodge G, Hodge S, Chambers D, Reynolds PN, Holmes M. Acute lung transplant rejection is associated with localized increase in T-cell IFNgamma and TNFalpha proinflammatory cytokines in the airways. Transplantation 2007;84:1452-1458.
53. Reams BD, Musselwhite LW, Zaas DW, Steele MP, Garantziotis S, Eu PC, Snyder LD, Curl J, Lin SS, Davis RD, et al. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant 2007;7:2802-2808.
54. Stovold R, Forrest IA, Corris PA, Murphy DM, Smith JA, Decalmer S, Johnson GE, Dark JH, Pearson JP, Ward C. Pepsin, a biomarker for gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med 2007;175:1298-1303.
55. Ward C, Forrest IA, Brownlee IA, Johnson GE, Murphy DM, Pearson JP, Dark JH, Corris PA. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005;60:872-874.
56. Hartwig MG, Appel JZ, Li B, Hsieh CC, Yoon YH, Lin SS, Irish W, Parker W, Davis RD. Chronic aspiration of gastric fluid accelerates pulmonary allograft dysfunction in a rat model of lung transplantation. J Thorac Cardiovasc Surg 2006;131:209-217.
57. Blondeau K, Mertens V, Vanaudenaerde BA, Verleden GM, Van Raemdonck DE, Sifrim D, Dupont LJ. Acid, non-acid GER and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2007;31:707-713.
58. Muylem AV, Knoop C, Estenne M. Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 2007;175:731-736.
59. Gast KK, Biedermann A, Herweling A, Schreiber WG, Schmiedeskamp J, Mayer E, Heussel CP, Markstaller K, Kauczor HU, Eberle B. Oxygen sensitive (3)He-MRI in bronchiolitis obliterans after lung transplantation. Eur Radiol 2007;18:530-537.
60. Babu AN, Mukarawa T, Thurman JM, Miller EJ, Henson PM, Zamora MR, Voelkel NF, Nicolls MR. Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. J Clin Invest 2007;117:3774-3785.
61. Luckraz H, Goddard M, McNeil K, Atkinson C, Sharples L D, Wallwork J. Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg 2006;82:1212-1218.
62. 1 after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med 2007;175:1192-1198.
63. Maessier E, Lorec AM, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M. T regulatory cells in stable post transplant bronchiolitis obliterans syndrome. Transplantation 2007;84:908-916.
64. Mason DP, Marsh DH, Alster JM, Murthy SC, McNeill AM, Budev MM, Mehta AC, Pettersson GB, Blackstone EH. Atrial fibrillation after lung transplantation: timing, risk factors, and treatment. Ann Thorac Surg 2007;84:1878-1884.
65. Mason DP, Solovera-Rozas M, Feng J, Rajeswaran J, Thuita L, Murthy SC, Budev MM, Mehta AC, Haug M 3rd, McNeill AM, Pettersson GB, Blackstone EH. Dialysis after lung transplantation: prevalence, risk factors and outcome. J Heart Lung Transplant 2007;26:1155-1162.